Interesting study examining novel way to quantify inflammation when CRP is not typically useful in psoriatic disease. Biomarkers such as IL8, lipocalin 2, calprotectin, IL22 & beta defensin 2 are useful in a spectrum of pts with skin v entheseal v joints inv #eular2019 @RheumNow https://t.co/UHPjnrJuks